SCP Clinical Research Intermediate Holdings, LLC – Trademark Portfolio
Entity Type: 16
SCP Clinical Research Intermediate Holdings, LLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PHASEWELL RESEARCH. The owner is based in Wilmington, DE.
1209 Orange St.
Wilmington, DE 19801
Showing of trademarks Trademarks
Trademark Classifications
SCP Clinical Research Intermediate Holdings, LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does SCP Clinical Research Intermediate Holdings, LLC have?
SCP Clinical Research Intermediate Holdings, LLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does SCP Clinical Research Intermediate Holdings, LLC file in?
SCP Clinical Research Intermediate Holdings, LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific). Class 35 covers advertising; business management; business administration; office functions.
What are SCP Clinical Research Intermediate Holdings, LLC's most well-known trademarks?
SCP Clinical Research Intermediate Holdings, LLC's registered trademark portfolio includes well-known marks such as PHASEWELL RESEARCH. These are among 1 currently registered trademark in the portfolio.
What is SCP Clinical Research Intermediate Holdings, LLC's trademark registration success rate?
SCP Clinical Research Intermediate Holdings, LLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.